8-K: Rubicon Technologies Faces NYSE Delisting Threat After Falling Below Minimum Market Cap and Share Price Standards

Rubicon Technologies has received notice from the NYSE for non-compliance with listing standards due to low market capitalization and share price.

Summary

• Rubicon Technologies received a notice from the New York Stock Exchange (NYSE) on March 18, 2024, stating that the company is not in compliance with continued listing standards.
• The company's average global market capitalization fell below $50 million over a 30-day trading period, and its last reported stockholders' equity was also less than $50 million.
• Additionally, the average closing price of Rubicon's Class A common stock was less than $1.00 per share over a consecutive 30-day trading period.
• Rubicon has 45 days from the notice to submit a plan to the NYSE to regain compliance with the market capitalization standard within 18 months.
• The company also has six months to regain compliance with the minimum stock price standard, requiring a closing price and average closing price of at least $1.00 per share at the end of any month during this period.
• Rubicon's stock will continue to trade on the NYSE during these cure periods, subject to other listing requirements.

Sentiment

Score: 3

Explanation: The document indicates significant financial distress and a potential delisting, which is a negative development for investors. The company is facing serious challenges to maintain its listing status.

Positives

• Rubicon's stock will continue to be listed and traded on the NYSE during the cure periods.
• The company has time to develop and implement a plan to regain compliance with the NYSE listing standards.

Negatives

• Rubicon is not in compliance with the NYSE's minimum market capitalization and share price standards.
• The company's average market capitalization and stockholders' equity are both below $50 million.
• The average closing price of the company's stock is below $1.00.
• There is a risk of delisting if the company fails to regain compliance within the specified timeframes.

Risks

• Failure to submit an acceptable plan to the NYSE within 45 days could lead to delisting proceedings.
• If the company does not regain compliance with the minimum market capitalization standard within 18 months, it could be delisted.
• If the company does not regain compliance with the minimum stock price standard within six months, it could be delisted.
• The company's stock price may be negatively impacted by the non-compliance notice.

Future Outlook

Rubicon intends to develop and submit a plan to the NYSE to regain compliance with the minimum market capitalization standard within 18 months and is considering alternatives to cure the stock price non-compliance, potentially requiring stockholder approval at the next annual meeting.

Management Comments

• The company intends to develop and submit a plan to bring it into compliance with the Minimum Market Capitalization Standard within the required time frame.
• Rubicon is currently evaluating its available options and developing a plan to regain compliance with the minimum global market capitalization requirement.

Industry Context

This announcement highlights the challenges faced by companies with declining market capitalization and share prices, particularly in the current economic environment. It is not uncommon for companies to receive delisting notices, and the ability to recover depends on the company's strategic plan and execution.

Comparison to Industry Standards

• Many companies in the technology sector, especially those that are not yet profitable, can face challenges in maintaining minimum market capitalization and share price requirements.
• Companies like WeWork and Bed Bath & Beyond have faced similar delisting issues, highlighting the importance of financial stability and investor confidence.
• The NYSE has specific rules and procedures for companies that fall below these standards, and Rubicon's situation is not unique in this context.
• The 18-month cure period for market capitalization and 6-month cure period for share price are standard timelines provided by the NYSE.

Stakeholder Impact

• Shareholders face the risk of delisting and potential loss of investment value.
• Employees may experience uncertainty due to the company's financial challenges.
• Customers and suppliers may be concerned about the company's long-term viability.

Next Steps

• Rubicon will develop and submit a plan to the NYSE within 45 days to regain compliance with the market capitalization standard.
• The company will consider alternatives to cure the stock price non-compliance, potentially requiring stockholder approval at the next annual meeting.
• Rubicon will continue to trade on the NYSE during the cure periods, subject to other listing requirements.

Key Dates

Keywords

NYSE, delisting, market capitalization, share price, compliance, Rubicon Technologies, RBT, stock price, listing standards